Meng Chao

ORCID: 0000-0002-9011-6693
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ocular Diseases and Behçet’s Syndrome
  • Retinal and Optic Conditions
  • Peripheral Neuropathies and Disorders
  • Cerebral Venous Sinus Thrombosis
  • IgG4-Related and Inflammatory Diseases
  • Chemotherapy-induced cardiotoxicity and mitigation
  • ATP Synthase and ATPases Research
  • Ginseng Biological Effects and Applications
  • Hemoglobinopathies and Related Disorders
  • Cancer Treatment and Pharmacology
  • Mitochondrial Function and Pathology
  • GDF15 and Related Biomarkers
  • Lung Cancer Treatments and Mutations
  • Lymphoma Diagnosis and Treatment
  • Lipoproteins and Cardiovascular Health
  • Antioxidant Activity and Oxidative Stress
  • interferon and immune responses
  • Natural product bioactivities and synthesis
  • Gestational Diabetes Research and Management
  • Herpesvirus Infections and Treatments
  • Gastric Cancer Management and Outcomes
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Diabetes Management and Research

Capital Medical University
2017-2021

Beijing Tongren Hospital
2017-2021

Tongren Hospital
2021

ORCID
2021

Zaozhuang Municipal Hospital
2020

Peking University
2018

Peking University International Hospital
2018

Shandong University
2010

Jinan Central Hospital
2010

Renji Hospital
2005

Abstract Ischemia/reperfusion (I/R) injury accounts to be a prime cause of neurological deficit following stroke. This study aimed explore the neuro‐protective effects Xanthoangelol (XAG) on I/R‐induced in both vivo and vitro models. Our data demonstrated that XAG can shrink infarct size brain edema middle cerebral artery occlusion (MCAO) model. In addition, was capable alleviating rats have undergone MCAO procedure. Meanwhile, antiapoptotic activities against neuronal were evidenced further...

10.1002/ar.24481 article EN The Anatomical Record 2020-06-27

Primary optic neuropathy in Behçet's syndrome (PONBS) is limited to a few case reports.To investigate the clinical features, magnetic resonance imaging (MRI) changes, and visual prognosis of PONBS.Sixty-one patients who presented with first onset neuritis fulfilled International Criteria for Disease (ICBD) were evaluated.The female-to-male ratio was 1.7:1. No patient had other central nervous system (CNS) disease. In 67 eyes nerve abnormalities on MRI scan, perineural enhancement around...

10.1177/1352458518786058 article EN Multiple Sclerosis Journal 2018-07-09

Objective: To explore the clinical characteristics and prognosis of chronic relapsing inflammatory optic neuropathy (CRION). Methods: A retrospective analysis was conducted. Clinical features, disease course, magnetic resonance imaging (MRI) patients with CRION who were admitted to Department Neurology between 2014 2016 reviewed analyzed. Results: Totally, there 27 (10 males 17 females), an age range 17-59 years. The duration 40 days 8 There 2 9 episodes. mean frequency episodes 3.30±1.56....

10.3760/cma.j.issn.0376-2491.2018.06.011 article EN PubMed 2018-02-06

Objective: To investigate the clinical characteristics, treatment and prognosis of optic neuropathy associated with varicella zoster virus (VZV). Methods: Five cases VZV infection from Department Neurology between January 1, 2014 March 31, 2019 were retrospectively collected. The manifestations, analyzed. Results: There 7 eyes involved in 5 cases, 3 (3/5) only one eye, 2 (2/5) both nerves. During follow-up time, no recurrence was found. Severe visual impairment occurred 4 (4/7) non-severe...

10.3760/cma.j.cn112137-20191023-02305 article EN PubMed 2020-06-16

Objective To report the presentation, clinical course and prognosis of intracranial hypertension (IH) with essential thrombocythemia (ET). Methods Retrospective data analysis was conducted. Seven cases IH ET were reviewed between January 2010 December 2016. The features, relationship analyzed. Results IH complicated more common among young middle-aged women. Sub acute or chronic common. easily misdiagnosed as optic neuritis in early stage. median platelet count seven patients...

10.3760/cma.j.issn.1006-7876.2017.12.009 article EN Chin J Neurol 2017-12-08

10.3971/j.issn.1000-8578.2018.18.0993 article EN DOAJ (DOAJ: Directory of Open Access Journals) 2018-11-01

Objective: To summarize the clinical manifestation, treatment and prognosis of anterior ischemic optic neuropathy(AION) which was manifestation neuropathy related with Behcet's disease (BD). Methods: Retrospective series case studies. The data 6 cases (9 eyes) AION associated BD who were hospitalized at neurology ward Beijing Tongren Hospital from February to June in 2016 collected, characteristics these patients summarized, visual acuity compared by using Wingerchuk grade before after...

10.3760/cma.j.issn.0412-4081.2019.03.009 article EN PubMed 2019-03-11

Objective: To investigate the clinical characteristics and prognosis of myelin oligodendrocyte glycoprotein (MOG) antibody-positive optic neuritis (ON). Methods: The data 39 patients with MOG ON in Department Neurology Beijing Tongren Hospital, Capital Medical University from January 1, 2017 to October 31, 2019 were retrospectively collected. There 25 males 14 females, aged 15 80 (40±16) years. According recurrence, divided into two groups: recurrence group (n=12) non-recurrence (n=27)....

10.3760/cma.j.cn112137-20200915-02649 article EN Zhonghua yixue zazhi 2021-05-01

Abstract Objective To shed light on the clinical characteristics, magnet resonance imaging(MRI) changes, and prognosis of myelin oligodendrocyte glycoprotein antibody (MOG-IgG) positive OPN in Han Chinese. Methods We observed 39 MOG-IgG patients our ward from January 1, 2017 , to December 31, 2019. Twenty met inclusion criteria included contrast enhancement surrounding optic nerve, at least one following symptoms: 1) reduction visual acuity, 2) impairment field, 3) eye pain. Single course...

10.21203/rs.3.rs-266843/v1 preprint EN cc-by Research Square (Research Square) 2021-03-16
Coming Soon ...